Pliant Therapeutics Inc. (PLRX) Statistics & Valuation Metrics - Stocknear

Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.86
0.23 (14.11%)
At close: Sep 05, 2025, 3:59 PM
1.74
-6.45%
After-hours: Sep 05, 2025, 06:18 PM EDT

Pliant Therapeutics Statistics

Share Statistics

Pliant Therapeutics has 61.39M shares outstanding. The number of shares has increased by 0.96% in one year.

61.39M
0.96%
0.24%
93.6%
54.04M
300
0.03%

Short Selling Information

The latest short interest is 3.32M, so 5.41% of the outstanding shares have been sold short.

3.32M
5.41%
5.54%
2.59

Valuation Ratios

The PE ratio is -3.79 and the forward PE ratio is -0.9. Pliant Therapeutics's PEG ratio is -0.14.

-3.79
-0.9
0
60.9
2.62
-5
-0.14
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pliant Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 10.91, with a Debt / Equity ratio of 0.2.

10.91
10.91
0.2
-0.26
-0.38
-75.52

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.23M
171
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -85.55% in the last 52 weeks. The beta is 1.44, so Pliant Therapeutics's price volatility has been higher than the market average.

1.44
-85.55%
1.5
4.73
65.99
1,183,885

Income Statement

n/a
-2.13M
-228.37M
-210.3M
-228.37M
-189.22M
-3.47
Full Income Statement

Balance Sheet

The company has 71.19M in cash and 60.19M in debt, giving a net cash position of 11M.

71.19M
60.19M
11M
-710.05M
299.82M
246.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -155.5M and capital expenditures -3.85M, giving a free cash flow of -159.35M.

-155.5M
-3.85M
-159.35M
-2.63
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PLRX is $3, which is 61.3% higher than the current price. The consensus rating is "Hold".

$3
61.3%
Hold
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.3
3